Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2004 2
2005 4
2006 4
2007 4
2008 1
2010 1
2018 3
2019 1
2020 2
2021 2
2023 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Anomalies in the review process and interpretation of the evidence in the NICE guideline for chronic fatigue syndrome and myalgic encephalomyelitis.
White P, Abbey S, Angus B, Ball HA, Buchwald DS, Burness C, Carson AJ, Chalder T, Clauw DJ, Coebergh J, David AS, Dworetzky BA, Edwards MJ, Espay AJ, Etherington J, Fink P, Flottorp S, Garcin B, Garner P, Glasziou P, Hamilton W, Henningsen P, Hoeritzauer I, Husain M, Huys AML, Knoop H, Kroenke K, Lehn A, Levenson JL, Little P, Lloyd A, Madan I, van der Meer JWM, Miller A, Murphy M, Nazareth I, Perez DL, Phillips W, Reuber M, Rief W, Santhouse A, Serranova T, Sharpe M, Stanton B, Stewart DE, Stone J, Tinazzi M, Wade DT, Wessely SC, Wyller V, Zeman A. White P, et al. J Neurol Neurosurg Psychiatry. 2023 Dec;94(12):1056-1063. doi: 10.1136/jnnp-2022-330463. Epub 2023 Jul 10. J Neurol Neurosurg Psychiatry. 2023. PMID: 37434321 Review.
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of unknown cause. The National Institute for Health and Care Excellence (NICE) published a guideline in 2021 that highlighted the seriousness of the condition, but also recommend …
Chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) is a disabling long-term condition of unknown cause. The National Institute for …
Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group.
Seelisch J, Sung L, Kelly MJ, Raybin JL, Beauchemin M, Dvorak CC, Kelly KP, Nieder ML, Noll RB, Thackray J, Ullrich NJ, Cabral S, Dupuis LL, Robinson PD. Seelisch J, et al. Pediatr Blood Cancer. 2019 Jan;66(1):e27471. doi: 10.1002/pbc.27471. Epub 2018 Sep 26. Pediatr Blood Cancer. 2019. PMID: 30259647 Free PMC article.
Providing evidence-based supportive care for children with cancer has the potential to optimize treatment outcomes and improve quality of life. The Children's Oncology Group (COG) Supportive Care Guidelines Subcommitt …
Providing evidence-based supportive care for children with cancer has the potential to optimize treatment …
Impact of the Children's Oncology Group's supportive care clinical practice guideline endorsement program: An institutional survey.
Marchak JG, Beauchemin MP, Broglie L, Kelly KP, Seelisch J, Dupuis LL; Children's Oncology Group Supportive Care Guidelines Task Force. Marchak JG, et al. Pediatr Blood Cancer. 2024 Oct;71(10):e31178. doi: 10.1002/pbc.31178. Epub 2024 Jul 15. Pediatr Blood Cancer. 2024. PMID: 39010277
BACKGROUND: Supportive care clinical practice guidelines (CPGs) facilitate the incorporation of the best available evidence into pediatric cancer care. ...Improvement in local implementation is required to ensure that patients at COG sites recei …
BACKGROUND: Supportive care clinical practice guidelines (CPGs) facilitate the incorporation of the best available evid …
The treatment of depression in cancer patients: a systematic review.
Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK; Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. Rodin G, et al. Support Care Cancer. 2007 Feb;15(2):123-36. doi: 10.1007/s00520-006-0145-3. Epub 2006 Oct 21. Support Care Cancer. 2007. PMID: 17058100 Review.
GOALS OF THE WORK: To evaluate the efficacy of pharmacological and nonpharmacological treatments for depression in cancer populations. MATERIALS AND METHODS: The Supportive Care Guidelines Group conducted a systematic review of the published lit …
GOALS OF THE WORK: To evaluate the efficacy of pharmacological and nonpharmacological treatments for depression in cancer populations …
The management of dyspnea in cancer patients: a systematic review.
Viola R, Kiteley C, Lloyd NS, Mackay JA, Wilson J, Wong RK; Supportive Care Guidelines Group of the Cancer Care Ontario Program in Evidence-Based Care. Viola R, et al. Support Care Cancer. 2008 Apr;16(4):329-37. doi: 10.1007/s00520-007-0389-6. Epub 2008 Jan 24. Support Care Cancer. 2008. PMID: 18214551 Review.
Four reviewers selected evidence using predefined criteria: controlled trials not limited to cancer and involving the specified drug classes for dyspnea treatment. MAIN RESULTS: Three systematic reviews, one with meta-analysis, two practice guidelines, and 28 contro …
Four reviewers selected evidence using predefined criteria: controlled trials not limited to cancer and involving the specified drug …
The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.
Dingle BH, Rumble RB, Brouwers MC; Cancer Care Ontario's Program in Evidence-Based Care's Gastrointestinal Cancer Disease Site Group. Dingle BH, et al. Can J Gastroenterol. 2005 Dec;19(12):711-6. doi: 10.1155/2005/565479. Can J Gastroenterol. 2005. PMID: 16341310 Review.
Gemcitabine has demonstrated response in similar cancers. Considering the lack of treatment options for cholangiocarcinoma and gallbladder cancer, a systematic review of the evidence on gemcitabine use for these indications was performed. ...For patients not conside …
Gemcitabine has demonstrated response in similar cancers. Considering the lack of treatment options for cholangiocarcinoma and gallbl …
The treatment of lymphedema related to breast cancer: a systematic review and evidence summary.
Kligman L, Wong RK, Johnston M, Laetsch NS. Kligman L, et al. Support Care Cancer. 2004 Jun;12(6):421-31. doi: 10.1007/s00520-004-0627-0. Epub 2004 Apr 17. Support Care Cancer. 2004. PMID: 15095073 Review.
GOALS OF WORK: To provide an evidence summary report on the question: What are the treatment options for women with lymphedema following treatment for breast cancer? METHODS: Cancer Care Ontario's Supportive Care Guidelines …
GOALS OF WORK: To provide an evidence summary report on the question: What are the treatment options for women with lymphedema following tre …
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.
Goffin J, Lacchetti C, Ellis PM, Ung YC, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Goffin J, et al. J Thorac Oncol. 2010 Feb;5(2):260-74. doi: 10.1097/JTO.0b013e3181c6f035. J Thorac Oncol. 2010. PMID: 20101151 Free article. Review.
INTRODUCTION: Non-small cell lung cancer (NSCLC) frequently presents at an incurable stage, and a majority of patients will be considered for palliative chemotherapy at some point in their disease. ...METHODS: Studies of first-line chemotherapy regimens including ne …
INTRODUCTION: Non-small cell lung cancer (NSCLC) frequently presents at an incurable stage, and a majority of patients will be consid …
MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients.
Miranda-Silva W, Gomes-Silva W, Zadik Y, Yarom N, Al-Azri AR, Hong CHL, Ariyawardana A, Saunders DP, Correa ME, Arany PR, Bowen J, Cheng KKF, Tissing WJE, Bossi P, Elad S; Mucositis Study Group of the Multinational Association of Supportive Care in Cancer / International Society for Oral Oncology (MASCC/ISOO). Miranda-Silva W, et al. Support Care Cancer. 2021 Jul;29(7):3539-3562. doi: 10.1007/s00520-020-05803-4. Epub 2020 Nov 6. Support Care Cancer. 2021. PMID: 33156403
METHODS: This sub-analysis of the pediatric patient population is based on the systematic review conducted by the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISSO) published in 2019/2020. Studies …
METHODS: This sub-analysis of the pediatric patient population is based on the systematic review conducted by the Multinational Assoc …
Young Adult Cancer Survivorship: Recommendations for Patient Follow-up, Exercise Therapy, and Research.
Adams SC, Herman J, Lega IC, Mitchell L, Hodgson D, Edelstein K, Travis LB, Sabiston CM, Thavendiranathan P, Gupta AA. Adams SC, et al. JNCI Cancer Spectr. 2020 Oct 28;5(1):pkaa099. doi: 10.1093/jncics/pkaa099. eCollection 2021 Feb. JNCI Cancer Spectr. 2020. PMID: 33681702 Free PMC article. Review.
Recognition of similar issues in pediatric cancer survivors has prompted the development of evidence-based guidelines for late effects screening and care. However, corresponding evidence-based guidelines for AYAs have not be …
Recognition of similar issues in pediatric cancer survivors has prompted the development of evidence-based guideline …
24 results